Cochrane Abstracts
Neoadjuvant chemotherapy versus none for resectable gastric cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neoadjuvant Chemotherapy Versus None for Resectable Gastric Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer.
Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer. Accessed August 17, 2025.
Neoadjuvant chemotherapy versus none for resectable gastric cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer
Neoadjuvant Chemotherapy Versus None for Resectable Gastric Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 August 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neoadjuvant chemotherapy versus none for resectable gastric cancer
ID - 432013
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
